SCHEMBL6170258

SCHEMBL6170258

Nc1ccc2[nH]cc3ccccc3c-2c1=O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.34
CYP3A4 P08684 1/20 0.34
HPGD P15428 1/20 0.34
TSHR P16473 1/20 0.34
KEAP1 Q14145 1/20 0.34
HSD17B10 Q99714 1/20 0.34
PARP1 P09874 5/20 0.34
TDP1 Q9NUW8 2/20 0.33
CSNK2A2 P19784 1/20 0.33
CSNK2B P67870 1/20 0.33
CSNK2A1 P68400 1/20 0.33
POLB P06746 1/20 0.33
FGR P09769 1/20 0.32
PIM1 P11309 1/20 0.32
MAOA P21397 1/20 0.32
ADORA2A P29274 1/20 0.32
CSNK1A1 P48729 1/20 0.32
CSNK1D P48730 1/20 0.32
DYRK1A Q13627 1/20 0.32
HIPK2 Q9H2X6 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11568940 0.81 S100A4 (0.33) ALDH1A1CYP3A4HPGDTSHRKEAP1
SCHEMBL9039648 0.80 C1R (0.36) PARP1CSNK2A2CSNK2BCSNK2A1POLB
SCHEMBL11773632 0.80 ALOX5 (0.38) ALDH1A1HPGDHSD17B10PARP1CSNK2A2
SCHEMBL11214964 0.80 PARP1 (0.42) ALDH1A1CYP3A4HPGDTSHRKEAP1
SCHEMBL840996 0.80 DNMT1 (0.35) PARP1CSNK2A2CSNK2BCSNK2A1DNMT1
SCHEMBL5312559 0.79 PARP1 (0.33) ALDH1A1HSD17B10PARP1TDP1CSNK2A2
SCHEMBL3327474 0.78 PARP1 (0.45) ALDH1A1HPGDPARP1TDP1CSNK2A2
SCHEMBL9020742 0.76 ELANE (0.32) ALDH1A1HSD17B10PARP1TDP1CSNK2A2
SCHEMBL378547 0.74 DNMT1 (0.38) ALDH1A1HSD17B10PARP1TDP1CSNK2A2
Hydrochloric Acid SCHEMBL28299257 0.72 DNMT1 (0.37) ALDH1A1HSD17B10PARP1TDP1CSNK2A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6958347-B2 Aminophenanthridinone and aminophenanthridine as NPY-5 antagonists PFIZER INC. (US) 2005-10-25 US disclosed
US-6958347-B2 Aminophenanthridinone and aminophenanthridine as NPY-5 antagonists PFIZER INC. (US) 2005-10-25 US disclosed
EP-1578728-A1 5-AMINOPHENANTHRIDINE DERIVATIVES AS NPY-5 ANTAGONISTS Pfizer Products Inc. (US) 2005-09-28 EP disclosed
WO-2004054981-A1 5-AMINOPHENANTHRIDINE DERIVATIVES AS NPY-5 ANTAGONISTS PFIZER PRODUCTS INC. (US) 2004-07-01 WO disclosed
US-20040122038-A1 NPY-5 antagonists PFIZER INC 2004-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040122038-A1 NPY-5 antagonists NPY5R, NPY1R, NPY2R ALDH1A1 2832/4885CYP3A4 3008/4885HPGD 1033/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.